Generic Drug Substitution in Special Populations

Focus Groups About Drug Products As Used by The Food and Drug Administration

FDAl_IAA_17_037D_6_01_2017

Generic Drug Substitution in Special Populations

OMB: 0910-0677

⚠️ Notice: This form may be outdated. More recent filings and information on OMB 0910-0677 can be found here:

2020-01-10 - Extension without change of a currently approved collection

Document [pdf]

Download: pdf | pdf

IRB Chair Letter
IRB Chair Letter
Check here to enter IRB Chair LetterComment: 6-14-17 Dually signed IAA is attached to this
function. RPMS

Signed By:

IRB Chair

File Type	application/pdf
File Modified	2017-06-14
File Created	2017-06-14